期刊文献+

特发性血小板减少性紫癜患儿血清微小病毒B_(19)检测及意义 被引量:6

Detection of serum human parvovirus B_(19) in children with ITP
下载PDF
导出
摘要 目的探讨人微小病毒B19(HPVB19)感染与儿童特发性血小板减少性紫癜(ITP)发病的关系。方法采用酶联免疫法(ELISA)对46例ITP患儿利30例健康儿童的血清标本进行HPVB19-IgM、IgG及血小板相关抗体检测。结果46例ITP患儿血清中HPVB19抗体总刚性率43.48%(20/46),30例健康儿童HPVB19-IgM、IgG均为阴性,2组间差异有统计学意义(P<0.01);ITP组中急性型与慢性型之间HPVB19抗体总阳性率差异有统计学意义(P<0.05);病毒感染刚性患儿的血小板相关抗体明显高于病毒感染阴性患儿,差异有统计学意义(P<0.01)。结论ITP患儿血清中HPVB19抗体总刚性率高,尤其是急性型;HPVB19感染后可导致血小板相关抗体升高而致血小板减少。 Objective To investigate the relationship between parvovirus B19 (HPVB19) infection and idiopathic thrombocytopenic purpura(ITP). Methods HPVB19-IgM, IgG and Platelet autoantibodies were measured by enzyme-linked immunosorbent assay (ELISA) in serum specimens from 46 children with ITP and 30 healthy children. Results Twenty of the 46 cases with ITP were positive for HPVB19 antibodies, 30 health children were negative for HPVB19 antibodies, there was a significant difference between the groups(P 〈 0. 01 ). The HPVB19 positive rate of the acute stage was higher than that of the chronic stage in the group of ITP ( P 〈 0. 05 ). Platelet autoantibodies titer of patients in virus infection were significantly higher than that of patients without viral infection ( P 〈 0.01 ). Conclusion ITP might be associated with HPVB19 infection, especially in the Viral infection could lead to platelet autoantibodies rising and platelet count dropping. acute stage.
出处 《中国小儿血液与肿瘤杂志》 CAS 2007年第3期119-120,123,共3页 Journal of China Pediatric Blood and Cancer
关键词 小儿 特发性血小板减少性紫癜(ITP) 微小病毒B19 Children Idiopathic thrombocytopenic purpura Human parvovirus B19
  • 相关文献

参考文献13

二级参考文献29

  • 1张国成,许东亮,李佐华,王瑞华,王绮云.聚合酶链反应检测人细小病毒B19-DNA[J].第四军医大学学报,1993,14(6):463-464. 被引量:4
  • 2张国成.儿童细小病毒B19感染[J].国外医学(儿科学分册),1994,21(5):257-260. 被引量:12
  • 3Katsure K, Nomura S, Ohtami T, et al. Changes of immunological markers after autologous peripheral blood stem cell transplantion. J Cancer Rcs Clin Oncol 1998;124(11) :633.
  • 4张国成,国外医学.儿科分册,1994年,21卷,5期,257页
  • 5Cossart YE, Field AM, Cant B, et al. Parvovirus-like particles in human sera. Lancet, 1975, 1: 72-73.
  • 6Yoshimoto K, Rosenfeld S. Frickhofen N, et al. A second neutralizing epitope of B19 parvovirus implicates the spike region in the immune response. J Virol, 1991, 65: 7056-7060.
  • 7Brown KE, Cohen BJ. Haemagglutination by parvovirus B19. J Gen Virol, 1992, 73: 2147-2149.
  • 8Brown KE, Anderson SM, Young NS. E rythrocyte P antigen: cellular receptor for B19 parvovirus. Science, 1993, 262:114-117.
  • 9Naides SJ, Scharosch LL, Foto F, et al. Rheumatologic manifestations of human parvovirus B19 infection in adults: initial two-year clinical experience. Arthritis Rheum, 1990, 33: 1297-1309.
  • 10Chou TN, Hsu TC, Chen RM, et al. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). Lupus, 2000, 9:551-554.

共引文献278

同被引文献55

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部